1-O-[3-[1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carbonyl]oxypropyl] 4-O-[2-[(8R,9S,10R,11R,13R,14R,16R,17S)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] butanedioate

C48H59F2N3O12 — CID 140652561

IUPAC1-O-[3-[1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carbonyl]oxypropyl] 4-O-[2-[(8R,9S,10R,11R,13R,14R,16R,17S)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] butanedioate
SMILESCOc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)OCCCOC(=O)CCC(=O)OCC(=O)[C@]3(O)[C@H](C)C[C@@H]4[C@H]5CCC6=CC(=O)C=C[C@@]6(C)[C@]5(F)[C@H](O)C[C@]43C)cn(C3CC3)c12
InChIInChI=1S/C48H59F2N3O12/c1-26-19-34-33-10-7-28-20-30(54)13-14-45(28,3)47(33,50)36(55)22-46(34,4)48(26,61)37(56)25-65-39(58)12-11-38(57)63-17-6-18-64-44(60)32-24-53(29-8-9-29)40-31(42(32)59)21-35(49)41(43(40)62-5)52-16-15-51-27(2)23-52/h13-14,20-21,24,26-27,29,33-34,36,51,55,61H,6-12,15-19,22-23,25H2,1-5H3/t26-,27?,33-,34-,36-,45-,46-,47-,48-/m1/s1
InChIKeySOIROIFYBRQBCV-LRPQKWSBSA-N
MW908.00 g/mol
LogP4.61
Rot. Bonds14

About 1-O-[3-[1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carbonyl]oxypropyl] 4-O-[2-[(8R,9S,10R,11R,13R,14R,16R,17S)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] butanedioate

1-O-[3-[1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carbonyl]oxypropyl] 4-O-[2-[(8R,9S,10R,11R,13R,14R,16R,17S)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] butanedioate (PubChem CID 140652561) has the molecular formula C48H59F2N3O12 and a molecular weight of 908.00 g/mol. Its IUPAC name is 1-O-[3-[1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carbonyl]oxypropyl] 4-O-[2-[(8R,9S,10R,11R,13R,14R,16R,17S)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] butanedioate.

Molecular Properties

Compound Name1-O-[3-[1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carbonyl]oxypropyl] 4-O-[2-[(8R,9S,10R,11R,13R,14R,16R,17S)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] butanedioate
PubChem CID140652561
Molecular FormulaC48H59F2N3O12
Molecular Weight908.00 g/mol
Exact Mass907.41
IUPAC Name1-O-[3-[1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carbonyl]oxypropyl] 4-O-[2-[(8R,9S,10R,11R,13R,14R,16R,17S)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] butanedioate
SMILESCOc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)OCCCOC(=O)CCC(=O)OCC(=O)[C@]3(O)[C@H](C)C[C@@H]4[C@H]5CCC6=CC(=O)C=C[C@@]6(C)[C@]5(F)[C@H](O)C[C@]43C)cn(C3CC3)c12
InChIInChI=1S/C48H59F2N3O12/c1-26-19-34-33-10-7-28-20-30(54)13-14-45(28,3)47(33,50)36(55)22-46(34,4)48(26,61)37(56)25-65-39(58)12-11-38(57)63-17-6-18-64-44(60)32-24-53(29-8-9-29)40-31(42(32)59)21-35(49)41(43(40)62-5)52-16-15-51-27(2)23-52/h13-14,20-21,24,26-27,29,33-34,36,51,55,61H,6-12,15-19,22-23,25H2,1-5H3/t26-,27?,33-,34-,36-,45-,46-,47-,48-/m1/s1
InChIKeySOIROIFYBRQBCV-LRPQKWSBSA-N
XLogP4.61
TPSA200.00 Ų
H-Bond Donors3
H-Bond Acceptors15
Rotatable Bonds14
Heavy Atoms65
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500908.00
LogP ≤ 54.61
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 1-O-[3-[1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carbonyl]oxypropyl] 4-O-[2-[(8R,9S,10R,11R,13R,14R,16R,17S)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] butanedioate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-O-[3-[1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carbonyl]oxypropyl] 4-O-[2-[(8R,9S,10R,11R,13R,14R,16R,17S)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] butanedioate?
The IUPAC name of 1-O-[3-[1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carbonyl]oxypropyl] 4-O-[2-[(8R,9S,10R,11R,13R,14R,16R,17S)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] butanedioate (CID 140652561) is 1-O-[3-[1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carbonyl]oxypropyl] 4-O-[2-[(8R,9S,10R,11R,13R,14R,16R,17S)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] butanedioate.
What is the SMILES notation for 1-O-[3-[1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carbonyl]oxypropyl] 4-O-[2-[(8R,9S,10R,11R,13R,14R,16R,17S)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] butanedioate?
The canonical SMILES for 1-O-[3-[1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carbonyl]oxypropyl] 4-O-[2-[(8R,9S,10R,11R,13R,14R,16R,17S)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] butanedioate is COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)OCCCOC(=O)CCC(=O)OCC(=O)[C@]3(O)[C@H](C)C[C@@H]4[C@H]5CCC6=CC(=O)C=C[C@@]6(C)[C@]5(F)[C@H](O)C[C@]43C)cn(C3CC3)c12.
What is the InChIKey of 1-O-[3-[1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carbonyl]oxypropyl] 4-O-[2-[(8R,9S,10R,11R,13R,14R,16R,17S)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] butanedioate?
The InChIKey is SOIROIFYBRQBCV-LRPQKWSBSA-N. The full InChI is InChI=1S/C48H59F2N3O12/c1-26-19-34-33-10-7-28-20-30(54)13-14-45(28,3)47(33,50)36(55)22-46(34,4)48(26,61)37(56)25-65-39(58)12-11-38(57)63-17-6-18-64-44(60)32-24-53(29-8-9-29)40-31(42(32)59)21-35(49)41(43(40)62-5)52-16-15-51-27(2)23-52/h13-14,20-21,24,26-27,29,33-34,36,51,55,61H,6-12,15-19,22-23,25H2,1-5H3/t26-,27?,33-,34-,36-,45-,46-,47-,48-/m1/s1.
What are the key properties of 1-O-[3-[1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carbonyl]oxypropyl] 4-O-[2-[(8R,9S,10R,11R,13R,14R,16R,17S)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] butanedioate?
1-O-[3-[1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carbonyl]oxypropyl] 4-O-[2-[(8R,9S,10R,11R,13R,14R,16R,17S)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] butanedioate has a molecular weight of 908.00 g/mol, XLogP of 4.61, 14 rotatable bonds, 3 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for 1-O-[3-[1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carbonyl]oxypropyl] 4-O-[2-[(8R,9S,10R,11R,13R,14R,16R,17S)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] butanedioate is sourced from PubChem (CID 140652561), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).